Product Information
HYSINGLA ER 40 MG TABLET is a brand product labeled by Purdue Pharma LP, priced at $26.1905 per EA under NDC 59011027360. Its NADAC has been published 597 times since Mar 18, 2015.
FDA first approved this application on Nov 20, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Purdue Pharma LPNDC
59011027360
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA206627FDA Approved
11/20/2014
TE Code
AB
On Market Since
1/15/2015
Pharmacological Classes
Price Statistics
The NADAC for HYSINGLA ER 40 MG TABLET has been published 597 times since Mar 18, 2015, and over the history we have for it it has risen 107.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.1905 per EA |
|---|---|
| All-time high | $26.1959 (Aug 12, 2026) |
| All-time low | $12.4454 (Apr 22, 2015) |
| 52-week high | $26.1959 |
| 52-week low | $24.0247 |
| Median price | $18.7067 |
| Average price | $18.9130 |
| Largest weekly change | +9.5% (Jan 9, 2019) |
| Weeks tracked | 597 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydrocodone bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYSINGLA ER 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYSINGLA ER 40 MG TABLET, manufactured by Purdue Pharma LP, is $26.1905 per EA (NDC 59011027360), effective Aug 19, 2026.
How has the price of HYSINGLA ER 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYSINGLA ER 40 MG TABLET has risen 107.3%. It has been tracked across 597 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for HYSINGLA ER 40 MG TABLET?
Since Mar 18, 2015, the NADAC for HYSINGLA ER 40 MG TABLET has ranged from a low of $12.4454 (Apr 22, 2015) to a high of $26.1959 (Aug 12, 2026), with a median of $18.7067 per EA.
Are there cheaper alternatives to HYSINGLA ER 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HYSINGLA ER 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYSINGLA ER 40 MG TABLET?
HYSINGLA ER 40 MG TABLET (NDC 59011027360) is labeled by Purdue Pharma LP, and CMS classifies it as a brand product.